153 related articles for article (PubMed ID: 22934741)
1. Application of small molecules/macromolecules in ocular inflammatory diseases.
Liu B; Chan CC; Nussenblatt RB
Antiinflamm Antiallergy Agents Med Chem; 2012; 11(2):113-20. PubMed ID: 22934741
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive agents and nonsteroidal anti-inflammatory drugs for ocular immune and inflammatory disorders.
Hemady RK; Chan AS; Nguyen AT
Ophthalmol Clin North Am; 2005 Dec; 18(4):511-28, vi. PubMed ID: 16314216
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of antioxidants in the protection of uveitis complications.
Yadav UC; Kalariya NM; Ramana KV
Curr Med Chem; 2011; 18(6):931-42. PubMed ID: 21182473
[TBL] [Abstract][Full Text] [Related]
5. Treatment of ocular inflammation in children.
Thadani SM; Foster CS
Paediatr Drugs; 2004; 6(5):289-301. PubMed ID: 15449968
[TBL] [Abstract][Full Text] [Related]
6. Relative potency of tyrosol in the treatment of endotoxin-induced uveitis in rats.
Sato K; Mihara Y; Kanai K; Yamashita Y; Kimura Y; Itoh N
J Vet Med Sci; 2016 Nov; 78(10):1631-1634. PubMed ID: 27350009
[TBL] [Abstract][Full Text] [Related]
7. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.
Lima BR; Nussenblatt RB; Sen HN
Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):875-82. PubMed ID: 23521173
[TBL] [Abstract][Full Text] [Related]
9. Optimising drug therapy for non-infectious uveitis.
Shahab MA; Mir TA; Zafar S
Int Ophthalmol; 2019 Jul; 39(7):1633-1650. PubMed ID: 29961190
[TBL] [Abstract][Full Text] [Related]
10. Small molecules as therapy for uveitis: a selected perspective of new and developing agents.
Pleyer U; Algharably EA; Feist E; Kreutz R
Expert Opin Pharmacother; 2017 Sep; 18(13):1311-1323. PubMed ID: 28750572
[TBL] [Abstract][Full Text] [Related]
11. TNF inhibition for ophthalmic indications: current status and outlook.
Rifkin LM; Birnbaum AD; Goldstein DA
BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory therapy in uveitis.
Majumder PD; Sudharshan S; Biswas J
Recent Pat Inflamm Allergy Drug Discov; 2009 Nov; 3(3):188-94. PubMed ID: 19607645
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic non-infectious uveitis and scleritis.
Rossi DC; Ribi C; Guex-Crosier Y
Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
[TBL] [Abstract][Full Text] [Related]
14. [Acute tubulointerstitial nephritis associated with uveitis (TINU). Treatment of the ocular inflammation with mycophenolate mofetil].
Sánchez Román J; Castillo Palma MJ; Ocaña Medina C; Rueda Rueda T
Med Clin (Barc); 1998 Nov; 111(16):638. PubMed ID: 9881342
[No Abstract] [Full Text] [Related]
15. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis.
Gallego-Pinazo R; Dolz-Marco R; Martínez-Castillo S; Arévalo JF; Díaz-Llopis M
Inflamm Allergy Drug Targets; 2013 Feb; 12(1):38-45. PubMed ID: 23441991
[TBL] [Abstract][Full Text] [Related]
16. Uveitis.
Dunn JP
Prim Care; 2015 Sep; 42(3):305-23. PubMed ID: 26319340
[TBL] [Abstract][Full Text] [Related]
17. Biological agents for the treatment of uveitis.
Servat JJ; Mears KA; Black EH; Huang JJ
Expert Opin Biol Ther; 2012 Mar; 12(3):311-28. PubMed ID: 22339439
[TBL] [Abstract][Full Text] [Related]
18. Side-effects of anti-inflammatory therapy in uveitis.
Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents.
Chiou GC; Yao QS; Chang MS; Okawara T
J Ocul Pharmacol; 1994; 10(1):335-47. PubMed ID: 8207338
[TBL] [Abstract][Full Text] [Related]
20. Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome era.
Juliano RL; Astriab-Fisher A; Falke D
Mol Interv; 2001 Apr; 1(1):40-53. PubMed ID: 14993337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
